Oncology Dream Over?

Quote
anonymous said:
Oncology did not fail AGAIN.....that implies it failed the first time. The previous Oncology business unit had excellent products and a good future but the moron Andrew Witty traded it away to Novartis for their Consumer Division. Also, the Tesaro acquisition is paying off much better than anticipated as some of the risks were mitigated...the recent Jemperli head to head win against Keytruda for lung cancer, and the Zejula sales growth are most notable examples. My recomendation for the person who made this comment is to figure out how to be part of the solution.....not the problem.....or you need to go somewhere else.
Click to expand...
Ahh yes, “Sir” Andrew Witty. The CEO that sold oncology for a bag of beans and left us much shame with GSK China.
 






anonymous said:
Oncology did not fail AGAIN.....that implies it failed the first time. The previous Oncology business unit had excellent products and a good future but the moron Andrew Witty traded it away to Novartis for their Consumer Division. Also, the Tesaro acquisition is paying off much better than anticipated as some of the risks were mitigated...the recent Jemperli head to head win against Keytruda for lung cancer, and the Zejula sales growth are most notable examples. My recomendation for the person who made this comment is to figure out how to be part of the solution.....not the problem.....or you need to go somewhere else.
Click to expand...

Jemperli vs. Keytruda, phase II trial, with just over 200 total patients. Regardless, even if the Jemperli data was highly statistically significant, GSK would fuck it up. They should not be trusted to run a lemonade stand.
 






anonymous said:
Jemperli vs. Keytruda, phase II trial, with just over 200 total patients. Regardless, even if the Jemperli data was highly statistically significant, GSK would fuck it up. They should not be trusted to run a lemonade stand.
Click to expand...


Today AZN stock closed at 85% above where it closed 5 years ago. In contrast, GSK stock closed at 11% below where it closed 5 years ago. Now I'm no cosmetics salesperson, but I can tell you that there ain't enough lipstick in the world to cover up which one of these two companies is the pig.

AZN is a major player in oncology, and GSK is a wannabe. Just the facts, you don't have to like 'em, but ya cannot dispute them.

ding dong, Avon calling.
 






anonymous said:
Today AZN stock closed at 85% above where it closed 5 years ago. In contrast, GSK stock closed at 11% below where it closed 5 years ago. Now I'm no cosmetics salesperson, but I can tell you that there ain't enough lipstick in the world to cover up which one of these two companies is the pig.

AZN is a major player in oncology, and GSK is a wannabe. Just the facts, you don't have to like 'em, but ya cannot dispute them.

ding dong, Avon calling.
Click to expand...

GSK stock has disappointed for many years. The dividend is nice but one has to be concerned for the lack of growth in share , If the stock price performs badly for a prolonged period of time, GSK shareholders should become frustrated and look for changes to be made in the management team. Shareholders are part owners of the company so they can vote out board members if they are unhappy, I can't understand why Emma Walmsley continues to retain support from shareholders and the board.
 






anonymous said:
GSK stock has disappointed for many years. The dividend is nice but one has to be concerned for the lack of growth in share , If the stock price performs badly for a prolonged period of time, GSK shareholders should become frustrated and look for changes to be made in the management team. Shareholders are part owners of the company so they can vote out board members if they are unhappy, I can't understand why Emma Walmsley continues to retain support from shareholders and the board.
Click to expand...
 


































































Presented for your consideration is this Super Rare Casio PG-300 Guitar Synthesizer with built in iPD sound generator and 2 additional sound cards for even more programmable options. The guitar platform is an Ibanez, and all of the added goodies are courtesy of our friends at Casio. As can be seen in the pictures, this guitar is in nothing less than pristine condition. The 2-piece flamed Maple top is nothing short of stunning. The only other way to get one of these in this condition would be to get a DeLorean and go back to 1989. The Synthesizer sounds are built-in to the guitar. No external modules required. Again, 2 additional sound cards make for an extensive library of sounds to choose from. I purchased this new and kept it as a backup for all this time. Properly stored in my smoke free home studio.
 






























Top Bottom
Back
Quote